Literature DB >> 17264438

Recurrent acute hepatitis in patient receiving pulsed methylprednisolone for multiple sclerosis.

Debasish Das1, Iain Graham, James Rose.   

Abstract

We report clinically significant, recurrent acute hepatitis in a 48-year-old woman receiving pulsed treatment with methylprednisolone for multiple sclerosis. No other cause was found for the episodes and the temporal and histological correlations were consistent with immune-allergic type drug-induced hepatitis.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17264438

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


  5 in total

1.  Methylprednisolone-induced acute liver injury in a patient treated for multiple sclerosis relapse.

Authors:  Clement Bresteau; Sophie Prevot; Gabriel Perlemuter; Cosmin Voican
Journal:  BMJ Case Rep       Date:  2018-03-05

2.  Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review.

Authors:  Miguel Eugenio Zoubek; José Pinazo-Bandera; Aida Ortega-Alonso; Nelia Hernández; Javier Crespo; Fernando Contreras; Inmaculada Medina-Cáliz; Judith Sanabria-Cabrera; Rocío Sanjuan-Jiménez; Andrés González-Jiménez; Miren García-Cortés; M Isabel Lucena; Raúl J Andrade; Mercedes Robles-Díaz
Journal:  United European Gastroenterol J       Date:  2019-03-24       Impact factor: 4.623

3.  Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature.

Authors:  Krzysztof Gutkowski; Alina Chwist; Marek Hartleb
Journal:  Hepat Mon       Date:  2011-08       Impact factor: 0.660

4.  Hepatotoxicity after high-dose intravenous methylprednisolone in multiple sclerosis patients.

Authors:  Milagros Hidalgo de la Cruz; Jahir Andrés Miranda Acuña; Alberto Lozano Ros; María Vega Catalina; Emilio Salinero Paniagua; Gerardo Clemente Ricote; Clara Dionisia De Andrés Frutos; María Luisa Martínez Ginés
Journal:  Clin Case Rep       Date:  2017-06-09

5.  Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients.

Authors:  Viviana Nociti; Marco Biolato; Chiara De Fino; Assunta Bianco; Francesco Antonio Losavio; Matteo Lucchini; Giuseppe Marrone; Antonio Grieco; Massimiliano Mirabella
Journal:  Brain Behav       Date:  2018-05-04       Impact factor: 2.708
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.